Swiss National Bank’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

Swiss National Bank’s Portfolio EGRX Stock Details EGRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-25,300	Closed	-$492K	–	2619
2023 Q2	$492K	Hold	25,300	–	–	﹤0.01%	2537
2023 Q1	$718K	Sell	25,300 -3,600	-12%	-$102K	﹤0.01%	2413
2022 Q4	$845K	Buy	28,900 +900	+3%	+$26.3K	﹤0.01%	2424
2022 Q3	$740K	Hold	28,000	–	–	﹤0.01%	2450
2022 Q2	$1.24M	Buy	28,000 +2,000	+8%	+$88.9K	﹤0.01%	2238
2022 Q1	$1.29M	Buy	26,000 +1,600	+7%	+$79.2K	﹤0.01%	2278
2021 Q4	$1.24M	Hold	24,400	–	–	﹤0.01%	2347
2021 Q3	$1.36M	Hold	24,400	–	–	﹤0.01%	2275
2021 Q2	$1.04M	Sell	24,400 -900	-4%	-$38.5K	﹤0.01%	2465
2021 Q1	$1.06M	Sell	25,300 -1,100	-4%	-$45.9K	﹤0.01%	2328
2020 Q4	$1.23M	Hold	26,400	–	–	﹤0.01%	2189
2020 Q3	$1.12M	Buy	26,400 +500	+2%	+$21.2K	﹤0.01%	2030
2020 Q2	$1.24M	Buy	25,900 +4,700	+22%	+$226K	﹤0.01%	1976
2020 Q1	$975K	Buy	21,200 +400	+2%	+$18.4K	﹤0.01%	1839
2019 Q4	$1.25M	Hold	20,800	–	–	﹤0.01%	2018
2019 Q3	$1.18M	Hold	20,800	–	–	﹤0.01%	1977
2019 Q2	$1.16M	Sell	20,800 -500	-2%	-$27.8K	﹤0.01%	2032
2019 Q1	$1.08M	Hold	21,300	–	–	﹤0.01%	2022
2018 Q4	$858K	Buy	21,300 +600	+3%	+$24.2K	﹤0.01%	2088
2018 Q3	$1.44M	Hold	20,700	–	–	﹤0.01%	1931
2018 Q2	$1.57M	Buy	20,700 +6,500	+46%	+$492K	﹤0.01%	1872
2018 Q1	$748K	Hold	14,200	–	–	﹤0.01%	2242
2017 Q4	$759K	Hold	14,200	–	–	﹤0.01%	2239
2017 Q3	$847K	Hold	14,200	–	–	﹤0.01%	2162
2017 Q2	$1.12M	Sell	14,200 -1,200	-8%	-$94.6K	﹤0.01%	1985
2017 Q1	$1.28M	Hold	15,400	–	–	﹤0.01%	1860
2016 Q4	$1.22M	Buy	15,400 +900	+6%	+$71.4K	﹤0.01%	1900
2016 Q3	$1.02M	Sell	14,500 -600	-4%	-$42K	﹤0.01%	1955
2016 Q2	$586K	Buy	15,100 +1,400	+10%	+$54.3K	﹤0.01%	2268
2016 Q1	$535K	Buy	13,700 +2,600	+23%	+$102K	﹤0.01%	2271
2015 Q4	$984K	Hold	11,100	–	–	﹤0.01%	1832
2015 Q3	$822K	Buy	11,100 +1,600	+17%	+$118K	﹤0.01%	1896
2015 Q2	$768K	Buy	+9,500	New	+$768K	﹤0.01%	1961